Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thiotepa via Ommaya Reservoir for Leptomeningeal Metastases in NSCLC
NCT07778940Phase 2Not yet recruiting
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Start
- Sep 2026
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
A Phase 2 trial of thiotepa in non-small cell lung cancer (NSCLC), leptomeningeal metastasis (LM), sponsored by Tianjin Medical University Cancer Institute and Hospital. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
thiotepa
03
Conditions
non-small cell lung cancer (NSCLC)leptomeningeal metastasis (LM)
Beyond the preview
Go deeper on NCT07778940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07778940.